证券记录 · 已归档季度
CATX
Perspective Therapeutics, Inc. · Healthcare · Medical - Devices
11被追踪持有人
0Δ持有人
24.99M持有股份
$85.98M报告持仓市值
+1新建仓位
−1清仓
动量输入（同类管理人）： 持有人广度 0.0% · 股份流向 +6.5% · 净新建仓位 0.0% — 公式
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q2 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 59 | -4 | 46.71M | $159.40M | +6 | −10 |
| Q1 2026 | 65 | +7 | 36.59M | $152.45M | +14 | −7 |
| Q4 2025 | 58 | +1 | 24.82M | $68.26M | +2 | −1 |
| Q3 2025 | 14 | 0 | 27.71M | $95.03M | +1 | −1 |
| Q2 2025 | 11 | 0 | 24.99M | $85.98M | +1 | −1 |
| Q1 2025 | 8 | -1 | 4.80M | $10.23M | +1 | −2 |
| Q4 2024 | 9 | +2 | 5.35M | $17.08M | +3 | −1 |
| Q3 2024 | 6 | -2 | 3.54M | $47.23M | +1 | −3 |
| Q2 2024 | 8 | — | 3.80M | $37.75M | — | — |
持有人 · Q2 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Fidelity (FMR) ✦ | 11.10M | — | $38.19M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | Fidelity (FMR) ✦ | 11.10M | — | $38.19M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | Fidelity (FMR) ✦ | 11.10M | — | $38.19M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | BlackRock ✦ (被动) | 4.29M | — | $14.77M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | BlackRock ✦ (被动) | 4.29M | — | $14.77M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | BlackRock ✦ (被动) | 4.29M | — | $14.77M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | BlackRock ✦ (被动) | 4.29M | — | $14.77M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | BlackRock ✦ (被动) | 4.29M | — | $14.77M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | BlackRock ✦ (被动) | 4.29M | — | $14.77M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | BlackRock ✦ (被动) | 4.29M | — | $14.77M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | The Vanguard Group ✦ (被动) | 3.27M | — | $11.26M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | The Vanguard Group ✦ (被动) | 3.27M | — | $11.26M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | The Vanguard Group ✦ (被动) | 3.27M | — | $11.26M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | Millennium Management ✦ | 2.59M | +2301.8% | $8.92M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 15 | Geode Capital Management ✦ (被动) | 1.38M | +15.8% | $4.76M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 16 | Geode Capital Management ✦ (被动) | 1.38M | +15.8% | $4.76M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 17 | State Street Global Advisors ✦ (被动) | 1.09M | +3.0% | $3.75M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 18 | Two Sigma Investments ✦ | 601.80K | -2.1% | $2.07M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 19 | Marshall Wace ✦ | 520.71K | -54.1% | $1.79M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 20 | Marshall Wace ✦ | 520.71K | -54.1% | $1.79M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 21 | Point72 Asset Management ✦ | 60.02K | 新增 | $206,474 | 0.0% | New | 1 | SEC ↗ |
| 22 | Citadel Advisors ✦ | 44.46K | -91.2% | $152,942 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 23 | T. Rowe Price ✦ | 28.79K | +22.8% | $100,000 | 0.0% | ▲ Add | 5 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| Point72 Asset Management | $206,474 | 0.0% |
已清仓
| Renaissance Technologies | $348,170 | 曾为 0.0% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 135 持有人, 78.53M 股份, $325.34M 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数，而非基本面关联。
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q2 2025 ·
方法论 ·
通过API获取此数据